If the Amplatzer Amulet Left Atrial Appendage (LAA) occlusion device gains approval in the U.S., the device could go head-to-head with Boston Scientific’s Watchman.
TAVR pioneer Edwards Lifesciences has released positive 30-day data of its Sapien 3 valve at EuroPCR.
Johnson & Johnson’s Cerenovus has stiff competition in the stent retriever market from both Stryker and Medtronic.
Robert Jarvik, MD, 2018 MDEA Lifetime Achievement Award winner, recalls defining moments of his medical innovation career.
Medtronic has initiated a clinical study to see if its Resolute Onyx DES can treat bifurcation lesions, which account for about 20% of all percutaneous coronary interventions.
Ancora Heart said FDA has approved an expansion of the company’s feasibility study to evaluate the AccuCinch Ventricular Repair System designed for the treatment of heart failure and functional mitral regurgitation (FMR).
The TMVR market continues to thrive, but Neovasc is having problems making a significant impact in the promising space, according to its most recent earnings report.
Bardy Diagnostics unveiled its artificial intelligence solution that can detect atrial fibrillation events at the 39th annual meeting of the Heart Rhythm Society.
Itamar Medical developed the SleePath to help electrophysiologists assess patients' sleep apnea status and CPAP compliance and correlate that data to the patient's atrial fibrillation manifestations to achieve optimal outcomes after catheter ablation.
Acutus Medical's AcQMap high-resolution imaging and mapping system is now being used in U.S. patients. Others in the space have also made noteworthy strides recently.
Integer will now turn its attention to its Cardio & Vascular and Cardiac & Neuromodulation offerings.
LivaNova topples Wall Street consensus on sales and EPS in its first quarter, but sees dip in shares.